Concepedia

H. Lynn Starr

HL

Statistics

Publications

22

Citations

904

H-Index

17

Active since

1944

Affiliations

Janssen (United States)(Current)

Janssen Scientific Affairs (United States)

Johnson & Johnson (United States)

University of California, Irvine

Consumer Healthcare Products Association

H. Lynn Starr is an author at Janssen (United States) specializing in psychopharmacology, pharmacology, and pharmacotherapy.

Publications per year

1944–2022

22

Publications

22

Real-World Outcomes of Paliperidone Palmitate Compared to Daily Oral Antipsychotic Therapy in Schizophrenia

Larry Alphs, Carmela Benson, Kimberly Cheshire-Kinney et al. · The Journal of Clinical Psychiatry · 2015 · 135 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Efficacy and Safety of OROS Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder

Lenard A. Adler, Brenda Zimmerman, H. Lynn Starr et al. · Journal of Clinical Psychopharmacology · 2009 · 109 citations

Medicine, Pharmacology, Pharmacotherapy +16

Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study

Jason E. Kemner, H. Lynn Starr, Patrick E. Ciccone et al. · Advances in Therapy · 2005 · 100 citations

Medicine, Pediatrics, Psychiatry +14

Academic, Behavioral, and Cognitive Effects of OROS <sup>®</sup> Methylphenidate on Older Children with Attention-Deficit/Hyperactivity Disorder

Sharon B. Wigal, Tim Wigal, Sabrina Schuck et al. · Journal of Child and Adolescent Psychopharmacology · 2011 · 57 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.

H. Lynn Starr, Jason E. Kemner · PubMed · 2005 · 55 citations

Medicine, Pediatrics, Psychiatry +17

1–5 of 22